Paul Tudor Jones's TNDM Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 78,999 shares of Tandem Diabetes Care, Inc. (TNDM) worth $1.51 M, representing 0.00% of the portfolio. First purchased in 2019-Q1, this long-term strategic position has been held for 24 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in TNDM, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 236,249 shares. Largest reduction occurred in Q3 2025, reducing 311,517 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Tandem Diabetes Care (TNDM) Holding Value Over Time
Track share changes against reported price movement
Quarterly Tandem Diabetes Care (TNDM) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -29,064 | Reduce 26.90% | 78,999 | $19.17 |
| Q4 2025 | +108,063 | New Buy | 108,063 | $21.98 |
| Q3 2025 | -311,517 | Sold Out | 0 | $0.00 |
| Q2 2025 | -93,775 | Reduce 23.14% | 311,517 | $18.64 |
| Q1 2025 | +236,249 | Add 139.76% | 405,292 | $19.16 |
| Q4 2024 | +128,294 | Add 314.84% | 169,043 | $36.02 |
| Q3 2024 | -24,477 | Reduce 37.53% | 40,749 | $42.41 |
| Q2 2024 | -12,109 | Reduce 15.66% | 65,226 | $40.29 |
| Q1 2024 | -154,403 | Reduce 66.63% | 77,335 | $35.41 |
| Q4 2023 | +16,356 | Add 7.59% | 231,738 | $29.58 |
| Q3 2023 | +8,292 | Add 4.00% | 215,382 | $20.77 |
| Q2 2023 | +136,914 | Add 195.10% | 207,090 | $24.54 |
| Q1 2023 | +70,176 | New Buy | 70,176 | $0.04 |
| Q4 2022 | -7,408 | Sold Out | 0 | $0.00 |
| Q3 2022 | -13,761 | Reduce 65.01% | 7,408 | $47.79 |
| Q2 2022 | +21,169 | New Buy | 21,169 | $59.19 |
| Q1 2022 | -29,551 | Sold Out | 0 | $0.00 |
| Q4 2021 | +29,551 | New Buy | 29,551 | $150.52 |
| Q3 2021 | -13,148 | Sold Out | 0 | $0.00 |
| Q2 2021 | +5,929 | Add 82.13% | 13,148 | $97.43 |
| Q1 2021 | +7,219 | New Buy | 7,219 | $88.24 |
| Q3 2019 | -49,724 | Sold Out | 0 | $0.00 |
| Q2 2019 | +31,917 | Add 179.24% | 49,724 | $64.52 |
| Q1 2019 | +17,807 | New Buy | 17,807 | $63.51 |
Paul Tudor Jones's Tandem Diabetes Care Investment FAQs
Paul Tudor Jones first purchased Tandem Diabetes Care, Inc. (TNDM) in Q1 2019, acquiring 17,807 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Tandem Diabetes Care, Inc. (TNDM) for 24 quarters since Q1 2019.
Paul Tudor Jones's largest addition to Tandem Diabetes Care, Inc. (TNDM) was in Q1 2025, adding 405,292 shares worth $7.77 M.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 78,999 shares of Tandem Diabetes Care, Inc. (TNDM), valued at approximately $1.51 M.
As of the Q1 2026 filing, Tandem Diabetes Care, Inc. (TNDM) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Tandem Diabetes Care, Inc. (TNDM) was 405,292 shares, as reported at the end of Q1 2025.